Document is current
Any future updates will be listed below
-
Authors
Wiggers, Caroline R. M. https://orcid.org/0000-0001-6633-1468
Cho, Eugene Y.
Ozdemir, Merve https://orcid.org/0009-0009-6825-6305
Bamgbose, Gbolahan
Hegel, Justin https://orcid.org/0009-0004-7091-8578
Frede, Julia
Warlitz, Frederike
Heavican-Foral, Tayla B. https://orcid.org/0000-0002-8384-6217
Pop, Ioana
Shraim, Rawan
Pölönen, Petri https://orcid.org/0000-0001-6128-9985
Koch, Victoria
Tran, Thai Hoa
Mullighan, Charles G. https://orcid.org/0000-0002-1871-1850
Teachey, David T. https://orcid.org/0000-0001-7373-8987
Bledsoe, Jacob R. https://orcid.org/0000-0002-2387-5462
Pikman, Yana https://orcid.org/0000-0002-5336-0216
Harris, Marian H. https://orcid.org/0000-0002-9956-664X
Place, Andrew E.
Silverman, Lewis B.
Lohr, Jens G. https://orcid.org/0000-0003-3486-2445
Knoechel, Birgit https://orcid.org/0000-0002-8040-0535
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01CA249185, X01HD100702)
Damon Runyon Cancer Research Foundation
Hyundai Motor Group | Hyundai Motor America | Hyundai Hope On Wheels
- License Information
-
More Information
Article History
Received: 25 September 2024
Accepted: 8 October 2025
First Online: 21 November 2025
Competing interests
: J.G.L. received research funding from Bristol Myers Squibb for an unrelated project. D.T.T. serves on advisory boards for AbbVie, Amgen, BEAM Therapeutics, Jazz, J&J Innovation (Janssen), Novartis, Pfizer, Sobi, Servier and Syndax without direct compensation. D.T.T receives research funding from BEAM Therapeutics and NeoImmune Tech. D.T.T. has patents or patents pending on CAR-T. C.G.M. reports research support from Pfizer and AbbVie; received honoraria from Amgen and Illumina; and reports equity in Amgen. The remaining authors declare that they have no competing interests.
